4//SEC Filing
Keane Raymond T 4
Accession 0001127602-13-011841
CIK 0000884731other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 6:38 PM ET
Size
8.3 KB
Accession
0001127602-13-011841
Insider Transaction Report
Form 4
Keane Raymond T
SVP General Counsel & CCO
Transactions
- Exercise/Conversion
Common Stock
2013-03-20+4,667→ 40,681 total - Sale
Common Stock
2013-03-22$19.46/sh−2,334$45,423→ 38,347 total - Exercise/Conversion
Restricted Stock Units
2013-03-20−4,667→ 0 total→ Common Stock (4,667 underlying)
Footnotes (4)
- [F1]Shares were acquired upon vesting of restricted stock units awarded on March 20, 2012.
- [F2]Represents shares withheld to satisfy withholding tax requirements.
- [F3]Each restricted stock unit represents a right to receive one share of ARIAD common stock.
- [F4]The restricted stock units vested on March 20, 2013.
Documents
Issuer
ARIAD PHARMACEUTICALS INC
CIK 0000884731
Entity typeother
Related Parties
1- filerCIK 0001448434
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 6:38 PM ET
- Size
- 8.3 KB